You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aclarubicin

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Nanjing (Venetoclax-Decitabine/Azacitidine-Aclarubicin Association,

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax-Decitabine/Azacitidine-Aclarubicin Association
  • Venetoclax-Decitabine/Azacitidine Association
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Mar 2, 2022

Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
May 16, 2022

Acute Myeloid Leukemia Trial in Shenyang (rhTPO)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
Feb 17, 2022

Vasculopathy, Retinal, With Cerebral Leukodystrophy, Cerebroretinal Vasculopathy, Hereditary Trial in Saint Louis (aclarubicin)

Completed
  • Vasculopathy, Retinal, With Cerebral Leukodystrophy
  • Cerebroretinal Vasculopathy, Hereditary
  • aclarubicin
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 17, 2020

Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed Trial in Guangzhou (Cladribine Injection, Aclarubicin, G-CSF)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Cladribine Injection
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020

Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028, Salvage Chemotherapy)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Chengdu, Sichuan, China
    West China hospital of Sichuan University
Nov 1, 2021

Acute Myeloid Leukemia, Relapse Leukemia Trial in Guangzhou (Cladribine, G-CSF, Aclarubicin)

Unknown status
  • Acute Myeloid Leukemia
  • Relapse Leukemia
  • Guangzhou, Guangdong, China
    Liang Wang
Aug 18, 2019

Acute Myeloid Leukemia Trial in Shenyang (rhTPO)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
Nov 17, 2019

Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax in combination with azacitidine and CAG
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022

Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

Recruiting
  • Refractory/Relapse Acute Myeloid Leukemia
  • Kunming, Yunnan, China
    Department of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023

Acute Myeloid Leukemia, Induction Chemo Trial in Suzhou (Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF)

Unknown status
  • Acute Myeloid Leukemia
  • Induction Chemotherapy
  • Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Sep 8, 2019

Acute Myeloid Leukemia, Venetoclax Trial in Kunming (combination of venetoclax and HAA regimen)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • combination of venetoclax and HAA regimen
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
May 29, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • Best-Available Therapy(BAT) Regimen
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 10, 2023

Induction Chemo, Acute T-Lymphocytic Leukemia, T-cell Lymphoblastic Lymphoma Leukemia Trial in Suzhou (Decitabine combined with

Recruiting
  • Induction Chemotherapy
  • +3 more
  • Decitabine combined with HAAG Regimen
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 22, 2020

Relapsed AML, T(8;21), C-KIT Mutation Trial in Tianjin (Dasatinib)

Withdrawn
  • Relapsed AML
  • +2 more
  • Tianjin, Tianjin, China
    HBDH
Mar 19, 2020

MDS-EB Trial in Fuzhou (Azacitidine, CAG Protocol)

Recruiting
  • MDS-EB
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Jan 1, 2020

Acute Lymphoblastic Leukemia Trial in GuangZhou (Cladribine, G-CSF, Cytarabine)

Unknown status
  • Acute Lymphoblastic Leukemia
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 18, 2019

Acute Myeloid Leukemia, Induction Chemo Trial in Suzhou (Decitabine plus HAAG regimen, Idarubicine plus Cytarabine regimen)

Unknown status
  • Acute Myeloid Leukemia
  • Induction Chemotherapy
  • Decitabine plus HAAG regimen
  • Idarubicine plus Cytarabine regimen
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 10, 2019

Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • The combination of HHT, venetoclax, AZA, G-CSF
  • (no location specified)
Mar 28, 2021

Acute Myeloid Leukemia Trial in Jinan (AraC, Aclarubicin, Peg-G-CSF)

Unknown status
  • Acute Myeloid Leukemia
  • Jinan, Shandong, China
    Qilu hospital, Shandong University
Feb 3, 2017

Hematopoietic System--Cancer Trial (Decitabine)

Unknown status
  • Hematopoietic System--Cancer
  • (no location specified)
Sep 30, 2018

AML, Relapse Trial in Beijing (Chidamide plus DCAG regimen)

Unknown status
  • AML
  • Relapse
  • Chidamide plus DCAG regimen
  • Beijing, China
    China PLA General Hospital
Feb 12, 2018

Carcinoma, Hepatocellular, Tumor Metastasis Trial in Greenville (yttrium Y 90 microspheres (Therasphere®))

No longer available
  • Carcinoma, Hepatocellular
  • Neoplasm Metastasis
  • yttrium Y 90 microspheres (Therasphere®)
  • Greenville, North Carolina
    Leo W Jenkins Cancer Center at East Carolina University School o
Aug 22, 2017

Hematological Remission Rates and Survival Among Chinese Adult

Completed
  • B-precursor Acute Lymphoblastic Leukemia
  • salvage therapy
  • Harbin, Heilongjiang, China
    Institute of Harbin Hematology Oncology
Apr 17, 2017

Spinal Muscular Atrophy Trial in Salt Lake City (Valproic Acid)

Completed
  • Spinal Muscular Atrophy
  • Valproic Acid
  • Salt Lake City, Utah
    University of Utah/Primary Children's Medical Center
Aug 22, 2016